IceCure Medical Stock Is On Fire After Hours: What's Going On?
IceCure Medical Stock Is On Fire After Hours: What's Going On?
IceCure Medical Ltd (NASDAQ:ICCM) shares are soaring in Monday's after-hours session after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
iCecure 医疗有限公司 纳斯达克股票代码：ICCM）股价在周一的盘后交易时段飙升，此前该公司公布了ICESECRET研究的中期结果，该研究旨在治疗无法接受保肾手术的肾脏肿块较小患者。
What Happened: IceCure said 107 of the 115 patients enrolled returned for follow-up with a mean duration of 22.8 months and a range of 12 to 60 months. The recurrence-free rate was 85.1% for the 107 patients at a mean follow-up period of 16.5 months.
发生了什么： IceCure说，在入组的115名患者中，有107名返回接受随访，平均持续时间为22.8个月，范围为12至60个月。在平均随访期为16.5个月的情况下，107名患者的无复发率为85.1％。
Five serious adverse events were reported, four of which were of mild severity. Cryoablation time and hospitalization time were relatively short, up to approximately 25 minutes and two days, respectively.
报告了五起严重的不良事件，其中四起为轻度不良事件。冷冻消融时间和住院时间相对较短，分别约为25分钟和两天。
Based on these interim results, it was concluded that cryoablation is safe and effective for treating renal masses under 5 centimeters.
根据这些中期结果，得出的结论是，冷冻消融对于治疗5厘米以下的肾脏肿块是安全有效的。
"We believe the findings will support further use of ProSense in the jurisdictions in which our cryoablation system is approved for use with benign and malignant tissues of the kidney," said Eyal Shamir, CEO of IceCure.
他说：“我们相信这些发现将支持在我们的冷冻消融系统获准用于肾脏良性和恶性组织的司法管辖区进一步使用ProSense。” 埃亚尔·沙米尔，iCecure首席执行官。
IceCure develops and markets ProSense, an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing.
IceCure开发并销售ProSense，这是一种先进的液氮基冷冻消融疗法，用于通过冷冻治疗肿瘤。
See Also: Why Entrada Therapeutics Stock Is Diving After Hours
另请参阅： 为什么 Entrada Therapeutics 的股票在下班后
ICCM Price Action: IceCure shares are up 760.60% in after hours at $8.03 at the time of publication, according to Benzinga Pro.
ICCM 价格走势： 根据Benzinga Pro的数据，IceCure股价在盘后上涨了760.60％，至发布时的8.03美元。
Photo: Dominik Fuchs from Pixabay.
照片： 多米尼克·福克斯 来自 Pixabay。